{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:03:27Z","timestamp":1788563007567,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd012658","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T00:00:00Z","timestamp":1599350400000}}],"reference-count":71,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012658.pub2","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T07:59:08Z","timestamp":1599724748000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Levonorgestrel-releasing intrauterine system for endometrial hyperplasia"],"prefix":"10.1002","volume":"2020","author":[{"given":"Theresa","family":"Mittermeier","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Auckland District Health Board; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Farrant","sequence":"additional","affiliation":[{"name":"Auckland District Health Board; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R","family":"Wise","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; The University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9,6]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD012658.pub2-BIB0001|cit1","first-page":"417","article-title":"Levonorgestrel-releasing intrauterine system is an efficient therapeutic modality for simple endometrial hyperplasia","volume":"9","author":"Abdelaziz","year":"2013","journal-title":"Journal of American Science"},{"issue":"2","key":"10.1002\/14651858.CD012658.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3802\/jgo.2013.24.2.128","article-title":"LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial","volume":"24","author":"Abu Hashim","year":"2013","journal-title":"Journal of Gynecologic Oncology"},{"issue":"8","key":"10.1002\/14651858.CD012658.pub2-BIB0003|cit3","first-page":"686","article-title":"Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia","volume":"19","author":"Behnamfar","year":"2014","journal-title":"Journal of Research in Medical Sciences"},{"issue":"6","key":"10.1002\/14651858.CD012658.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/1933719114561553","article-title":"Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia","volume":"22","author":"Bian","year":"2015","journal-title":"Reproductive Sciences (Thousand Oaks, Calif.)"},{"issue":"1","key":"10.1002\/14651858.CD012658.pub2-BIB0005|cit5","first-page":"122","article-title":"The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. A prospective randomized comparative study","volume":"40","author":"Dolapcioglu","year":"2013","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012658.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1933719114542014","article-title":"Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia","volume":"22","author":"El Behery","year":"2015","journal-title":"Reproductive Sciences (Thousand Oaks, Calif.)"},{"issue":"1","key":"10.1002\/14651858.CD012658.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1933719112459243","article-title":"Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia","volume":"20","author":"Ismail","year":"2013","journal-title":"Reproductive Sciences (Thousand Oaks, Calif.)"},{"issue":"3","key":"10.1002\/14651858.CD012658.pub2-BIB0008|cit8","first-page":"421","article-title":"A comparison of the effect of levonorgestrel IUD with oral medroxyprogesterone acetate on abnormal uterine bleeding with simple endometrial hyperplasia and fertility preservation","volume":"40","author":"Karimi-Zarchi","year":"2013","journal-title":"Clinical and Experimental Obstetrics & Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD012658.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/1471-0528.13763","article-title":"Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens","volume":"123","author":"Orbo","year":"2016","journal-title":"BJOG"},{"issue":"4","key":"10.1002\/14651858.CD012658.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1471-0528.13763","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial","volume":"121","author":"Orbo","year":"2014","journal-title":"BJOG"},{"issue":"1","key":"10.1002\/14651858.CD012658.pub2-BIB0011|cit11","first-page":"S340","article-title":"Levonorgestrel impregnated intrauterine device is efficient as therapy for endometrial hyperplasia: A national multi-centre randomised controlled trial","volume":"465","author":"Orbo","year":"2014","journal-title":"Virchows Archiv : an International Journal of Pathology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012658.pub2-BIB0012|cit12","first-page":"S49","article-title":"Comparison of levonorgestrel-releasing intrauterine system, medroxyprogesterone and norethisterone for treatment of endometrial hyperplasia without atypia","volume":"7","author":"Hamza","year":"2015","journal-title":"Journal of Endometriosis and Pelvic Pain Disorders"},{"issue":"4","key":"10.1002\/14651858.CD012658.pub2-BIB0013|cit13","first-page":"00163","article-title":"Comparison of levonorgestrel-releasing intrauterine system, medroxyprogesterone and norethisterone for treatment of endometrial hyperplasia without atypia: a randomized clinical trial","volume":"5","author":"Rezk","year":"2016","journal-title":"Obstetrics and Gynecology International"},{"issue":"2","key":"10.1002\/14651858.CD012658.pub2-BIB0014|cit14","first-page":"675","article-title":"Levonorgestrel Intrauterine System (LNG-IUS) versus medroxyprogesterone acetate for the treatment of endometrial hyperplasia: a randomized control trial","volume":"12","author":"Rizvi","year":"2018","journal-title":"Pakistan Journal of Medical and Health Sciences"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012658.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1097\/01.IGC.0000457075.08973.89","article-title":"Efficacy of different therapies in treatment of simple endometrial hyperplasia","volume":"24","author":"Yang","year":"2014","journal-title":"International Journal of Gynecological Cancer"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD012658.pub2-BIB0016|cit16","first-page":"1344","article-title":"Efficacy of different therapies in treatment of endometrial hyperplasia","volume":"24","author":"Yang","year":"2014","journal-title":"International Journal of Gynecological Cancer"},{"issue":"6","key":"10.1002\/14651858.CD012658.pub2-BIB0017|cit17","first-page":"580","article-title":"Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasiaand carcinoma","volume":"82","author":"Bahamondes","year":"2003","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"11","key":"10.1002\/14651858.CD012658.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD012658.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ygyno.2009.06.014","article-title":"Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial","volume":"114","author":"Gardner","year":"2009","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD012658.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000084142","article-title":"Treatment of non-atypic endometrial hyperplasia using thermal balloon endometrial ablation therapy","volume":"59","author":"J\u00e4rvel\u00e4","year":"2005","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"6","key":"10.1002\/14651858.CD012658.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/1097-0142","article-title":"Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium","volume":"12","author":"Kistner","year":"1959","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0022|cit22","unstructured":"La Russa M Biliatis I Brockbank E Faruki A Lawrence A Manchanda R Conservative treatment for fertility sparing in young women with endometrial cancer and atypical hyperplasia. Results from a on going prospective single centre study Available at qmro.qmul.ac.uk\/xmlui\/handle\/123456789\/18943"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0023|cit23","unstructured":"Omelchenko N Zolotukhin M Management of patients with climacteric syndrome and endometrial hyperplasia Climacteric, 10th World Congress on Menopause Berlin, Germany"},{"issue":"1","key":"10.1002\/14651858.CD012658.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2008.06.014","article-title":"Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-upstudy comparing effect of LNG-IUD and oral progestins versus observation only","volume":"111","author":"\u00d8rbo","year":"2008","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"10.1002\/14651858.CD012658.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000321390","article-title":"Comparison of the efficacy of three progestins in the treatment of simple endometrial hyperplasia without atypia","volume":"72","author":"Ozdegirmenci","year":"2011","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"3","key":"10.1002\/14651858.CD012658.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometriumin women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstetrics and Gynecology"},{"issue":"S4","key":"10.1002\/14651858.CD012658.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/S0959-8049(98)00116-6","article-title":"V.2 Use of levonorgestrel intrauterine device for prevention of endometrial changes induced by tamoxifen","volume":"34","author":"Van Liedekerke","year":"1998","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD012658.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2003.07.002","article-title":"Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone","volume":"91","author":"Vereide","year":"2003","journal-title":"Gynecologic Oncology"},{"issue":"7","key":"10.1002\/14651858.CD012658.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"31","author":"Wheeler","year":"2007","journal-title":"American Journal of Surgical Pathology"},{"issue":"5","key":"10.1002\/14651858.CD012658.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1067\/mob.2003.346","article-title":"Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasingintrauterine system","volume":"188","author":"Wildemeersch","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012658.pub2-BIB0031|cit31","first-page":"242","article-title":"[Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinomaand severe atypical hyperplasia in young women]","volume":"41","author":"Yu","year":"2006","journal-title":"Zhonghua Fu Chan Ke za Zhi"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0032|cit32","unstructured":"Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia clinicaltrials.gov\/ct2\/show\/NCT03241888"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0033|cit33","unstructured":"Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03463252"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0034|cit34","unstructured":"Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia clinicaltrials.gov\/ct2\/show\/NCT03992937"},{"issue":"4","key":"10.1002\/14651858.CD012658.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajog.2015.03.037","article-title":"Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomised trials","volume":"213","author":"Abu Hashim","year":"2015","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD012658.pub2-BIB0036|cit36","first-page":"131","article-title":"Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding","volume":"21","author":"Anastasiadis","year":"2000","journal-title":"European Journal of Gynaecological Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012658.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1479-828X.2009.00981.x","article-title":"The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review","volume":"49","author":"Buttini","year":"2009","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0038|cit38","unstructured":"Crosbie E Morrison J Editorial: The emerging epidemic of endometrial cancer: Time to take action www.cochranelibrary.com\/editorial\/10.1002\/14651858.ED000095 10.1002\/14651858.CD000095"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0039|cit39","volume-title":"Clinical Gynaecologic Oncology","author":"DiSaia","year":"2018"},{"issue":"12","key":"10.1002\/14651858.CD012658.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007245.pub3","article-title":"Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen","author":"Dominick","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012658.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"547.e1","DOI":"10.1016\/j.ajog.2010.07.037","article-title":"Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis","volume":"203","author":"Gallos","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD012658.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/humrep\/det320","article-title":"LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study","volume":"28","author":"Gallos","year":"2013","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD012658.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S1701-2163(16)32969-3","article-title":"Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasia","volume":"30","author":"Giede","year":"2008","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0044|cit44","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool McMaster University (developed by Evidence Prime, Inc.) 2015"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD012658.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.contraception.2007.01.015","article-title":"Endometrial effects of intrauterine levonorgestrel","volume":"75","author":"Guttinger","year":"2007","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0046|cit46","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0047|cit47","unstructured":"International Agency for Research on Cancer GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 v1.0 gco.iarc.fr\/"},{"issue":"12","key":"10.1002\/14651858.CD012658.pub2-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007926.pub2","article-title":"Hormonal therapy in advanced or recurrent endometrial cancer (Review)","author":"Kokka","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012658.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0050|cit50","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-0489-8","volume-title":"Blaustein's Pathology of the Female Genital Tract","author":"Kurman","year":"2011"},{"issue":"5","key":"10.1002\/14651858.CD012658.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1200\/JCO.2009.24.1315","article-title":"Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia","volume":"28","author":"Sherman","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-323-07419-3.00004-7","volume-title":"Clinical Gynecologic Oncology","author":"Landrum","year":"2012"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0053|cit53","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD012658.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002126.pub3","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012658.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009458.pub2","article-title":"Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia","author":"Luo","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012658.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009458.pub3","article-title":"Oral and intrauterine progestogens for atypical endometrial hyperplasia","author":"Luo","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012658.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/09513590.2012.730579","article-title":"Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women","volume":"29","author":"Morelli","year":"2013","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0058|cit58","unstructured":"Improving the Treatment for Women With Early Stage Cancer of the Uterus (feMMe) clinicaltrials.gov\/ct2\/show\/NCT01686126"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0059|cit59","unstructured":"National Institute for Health and Care Excellence Heavy menstrual bleeding: assessment and management. Clinical guideline [CG44]. Published date: January 2007. Last updated: August 2016 www.nice.org.uk\/guidance\/cg44"},{"issue":"1","key":"10.1002\/14651858.CD012658.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0061|cit61","unstructured":"Provera Medroxyprogesterone acetate data sheet October 2016 www.medsafe.govt.nz\/profs\/Datasheet\/p\/Proveratab.pdf"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0062|cit62","unstructured":"Gallos ID Alazzam M Clark TJ Faraj R Rosenthal AN Smith PP Management of Endometrial Hyperplasia. Green-top Guideline No. 67 www.rcog.org.uk\/globalassets\/documents\/guidelines\/green-top-guidelines\/gtg_67_endometrial_hyperplasia.pdf"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0063|cit63","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"2","key":"10.1002\/14651858.CD012658.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008994.pub2","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids","author":"Sangkomkamhang","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-85014-1","volume-title":"International Histological Classification of Tumours","author":"Scully","year":"1994"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD012658.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(15)30732-5","article-title":"SOGC Clinical Practice Guideline: abnormal uterine bleeding in pre-menopausal women","volume":"35","author":"Singh","year":"2013","journal-title":"Journal of Obstetrics and Gynaecology Canada"},{"issue":"4","key":"10.1002\/14651858.CD012658.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD012658.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jmig.2010.09.013","article-title":"The levonorgestrel intrauterine system Is an effective treatment in selected obese women with abnormal uterine bleeding","volume":"18","author":"Vilos","year":"2011","journal-title":"Journal of Minimally Invasive Gynecology"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0069|cit69","doi-asserted-by":"crossref","unstructured":"Wise M Jordan V Lagas A Showell M Wong N Lensen S Obesity and endometrial hyperplasia and cancer in premenopausal women: a systematic review American Journal of Obstetrics and Gynecology 2016 214 6 689.e1 e17 10.1016\/j.ajog.2016.01.175","DOI":"10.1016\/j.ajog.2016.01.175"},{"issue":"5","key":"10.1002\/14651858.CD012658.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1245\/s10434-016-5699-9","article-title":"Levonorgestrel-releasing intrauterine systems versus oral cyclic medroxyprogesterone acetate in endometrial hyperplasia therapy: a meta-analysis","volume":"25","author":"Yuk","journal-title":"Annals of Surgical Oncology"},{"key":"10.1002\/14651858.CD012658.pub2-BIB0071|cit71","first-page":"125","volume-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"Zaino","year":"2014"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T23:03:43Z","timestamp":1737327823000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012658.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,6]]},"references-count":71,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012658.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,6]]}}}